China Vanke Co Ltd
SZSE:000002
China Vanke Co Ltd
SZSE:000002
Price:
7.72
CNY
-1.28%
Market Cap:
87.3B
CNY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
China Vanke Co Ltd
7.72
-0.10 (-1.28%)
| 52 Week Range |
6.22
10.52
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
China Vanke Co Ltd
Balance Sheet
Balance Sheet Decomposition
China Vanke Co Ltd
China Vanke Co Ltd
| Current Assets | 1.1T |
| Cash & Short-Term Investments | 90B |
| Receivables | 296.2B |
| Other Current Assets | 692B |
| Non-Current Assets | 344.6B |
| Long-Term Investments | 236.3B |
| PP&E | 40.6B |
| Intangibles | 13.8B |
| Other Non-Current Assets | 53.9B |
| Current Liabilities | 786.4B |
| Accounts Payable | 193.3B |
| Accrued Liabilities | 44.6B |
| Short-Term Debt | 3.5B |
| Other Current Liabilities | 545.1B |
| Non-Current Liabilities | 394.7B |
| Long-Term Debt | 248B |
| Other Non-Current Liabilities | 146.7B |
Balance Sheet
China Vanke Co Ltd
China Vanke Co Ltd
Currency: CNY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
62 715
|
53 180
|
87 032
|
174 121
|
188 417
|
159 739
|
185 662
|
140 708
|
134 425
|
96 943
|
|
| Cash |
62 715
|
53 180
|
87 032
|
174 121
|
188 417
|
159 739
|
185 662
|
140 708
|
134 425
|
96 943
|
|
| Short-Term Investments |
36
|
122
|
459
|
12
|
11 912
|
12 068
|
185
|
21
|
63
|
209
|
|
| Total Receivables |
50 819
|
77 996
|
107 510
|
164 682
|
257 241
|
256 934
|
275 016
|
299 227
|
303 908
|
286 513
|
|
| Accounts Receivables |
1 894
|
2 511
|
2 075
|
1 433
|
2 950
|
5 433
|
9 155
|
15 134
|
18 432
|
20 972
|
|
| Other Receivables |
48 925
|
75 485
|
105 435
|
163 249
|
254 291
|
251 501
|
265 861
|
284 093
|
285 476
|
265 541
|
|
| Inventory |
317 726
|
368 122
|
467 361
|
598 088
|
750 303
|
897 019
|
1 002 063
|
1 075 617
|
907 057
|
701 696
|
|
| Other Current Assets |
33 509
|
47 604
|
58 934
|
80 649
|
87 199
|
113 231
|
84 461
|
84 695
|
69 904
|
64 899
|
|
| Total Current Assets |
464 806
|
547 024
|
721 295
|
1 017 553
|
1 295 072
|
1 438 989
|
1 547 387
|
1 600 268
|
1 415 356
|
1 150 260
|
|
| PP&E Net |
4 142
|
5 516
|
7 576
|
8 121
|
13 447
|
38 715
|
41 024
|
40 461
|
40 772
|
41 945
|
|
| PP&E Gross |
4 142
|
5 516
|
7 576
|
8 121
|
13 447
|
38 715
|
41 024
|
40 461
|
40 772
|
41 945
|
|
| Accumulated Depreciation |
833
|
1 009
|
1 410
|
1 781
|
3 122
|
5 929
|
8 643
|
11 603
|
14 433
|
16 219
|
|
| Intangible Assets |
878
|
1 045
|
1 260
|
1 438
|
4 953
|
5 270
|
6 088
|
10 445
|
11 548
|
10 956
|
|
| Goodwill |
202
|
202
|
202
|
206
|
217
|
221
|
206
|
3 822
|
5 402
|
5 409
|
|
| Long-Term Investments |
27 348
|
45 407
|
84 904
|
111 376
|
186 272
|
206 964
|
224 148
|
233 277
|
233 191
|
242 888
|
|
| Other Long-Term Assets |
11 034
|
12 101
|
15 436
|
26 653
|
28 619
|
39 770
|
50 323
|
50 364
|
50 856
|
53 391
|
|
| Other Assets |
202
|
202
|
202
|
206
|
217
|
221
|
206
|
3 822
|
5 402
|
5 409
|
|
| Total Assets |
508 409
N/A
|
611 296
+20%
|
830 674
+36%
|
1 165 347
+40%
|
1 528 579
+31%
|
1 729 929
+13%
|
1 869 177
+8%
|
1 938 638
+4%
|
1 757 124
-9%
|
1 504 850
-14%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
67 047
|
91 446
|
138 048
|
173 439
|
227 946
|
267 281
|
295 685
|
330 411
|
289 216
|
221 688
|
|
| Accrued Liabilities |
4 013
|
5 466
|
7 727
|
9 410
|
57 915
|
67 425
|
77 701
|
76 148
|
66 400
|
50 140
|
|
| Short-Term Debt |
23 675
|
18 645
|
20 180
|
19 439
|
25 752
|
16 748
|
25 646
|
14 522
|
4 144
|
1 070
|
|
| Current Portion of Long-Term Debt |
20 449
|
24 746
|
26 773
|
46 164
|
69 092
|
79 506
|
59 459
|
46 151
|
62 357
|
63 314
|
|
| Other Current Liabilities |
230 470
|
279 759
|
387 270
|
598 903
|
741 208
|
841 651
|
859 003
|
844 214
|
655 684
|
485 573
|
|
| Total Current Liabilities |
345 654
|
420 062
|
579 998
|
847 355
|
1 121 914
|
1 272 610
|
1 317 493
|
1 311 446
|
1 077 802
|
821 785
|
|
| Long-Term Debt |
46 149
|
52 844
|
85 514
|
128 352
|
168 024
|
185 243
|
200 203
|
231 652
|
271 655
|
277 280
|
|
| Deferred Income Tax |
590
|
558
|
504
|
265
|
539
|
282
|
231
|
1 290
|
1 140
|
1 137
|
|
| Minority Interest |
27 729
|
36 126
|
48 232
|
53 999
|
79 857
|
82 521
|
125 334
|
156 820
|
162 300
|
152 149
|
|
| Other Liabilities |
122
|
1 521
|
2 981
|
2 701
|
2 482
|
1 215
|
1 406
|
1 477
|
1 536
|
1 714
|
|
| Total Liabilities |
420 244
N/A
|
511 112
+22%
|
717 229
+40%
|
1 032 672
+44%
|
1 372 815
+33%
|
1 541 871
+12%
|
1 644 666
+7%
|
1 702 685
+4%
|
1 514 433
-11%
|
1 254 066
-17%
|
|
| Equity | |||||||||||
| Common Stock |
11 038
|
11 052
|
11 039
|
11 039
|
11 039
|
11 302
|
11 618
|
11 625
|
11 631
|
11 931
|
|
| Retained Earnings |
67 281
|
79 477
|
92 808
|
113 072
|
139 118
|
166 178
|
195 883
|
203 885
|
215 124
|
219 844
|
|
| Additional Paid In Capital |
9 284
|
9 364
|
9 202
|
8 329
|
8 006
|
12 384
|
18 554
|
20 584
|
22 868
|
25 052
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
550
|
5 507
|
4 840
|
|
| Treasury Stock |
0
|
160
|
0
|
0
|
0
|
0
|
0
|
0
|
1 292
|
1 292
|
|
| Other Equity |
562
|
451
|
396
|
235
|
2 399
|
1 806
|
1 544
|
409
|
131
|
89
|
|
| Total Equity |
88 165
N/A
|
100 184
+14%
|
113 445
+13%
|
132 675
+17%
|
155 764
+17%
|
188 058
+21%
|
224 511
+19%
|
235 953
+5%
|
242 691
+3%
|
250 785
+3%
|
|
| Total Liabilities & Equity |
508 409
N/A
|
611 296
+20%
|
830 674
+36%
|
1 165 347
+40%
|
1 528 579
+31%
|
1 729 929
+13%
|
1 869 177
+8%
|
1 938 638
+4%
|
1 757 124
-9%
|
1 504 850
-14%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
11 038
|
11 039
|
11 039
|
11 039
|
11 039
|
11 302
|
11 618
|
11 625
|
11 558
|
11 858
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
